Skip to main content

Neuromuscular Diseases clinical trials at UC Irvine
1 in progress, 0 open to new patients

  • AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)

    Sorry, in progress, not accepting new patients

    The CENTAUR trial will be a 2:1 (active:placebo) randomized, double-blind, placebo-controlled Phase II trial to evaluate the safety and efficacy of AMX0035 for the treatment of ALS.

    Orange, California and other locations

Last updated: